Our study shows ATF3 can be a biomarker for early predicting AKI after CPB, and the addition of urine ATF3 as a risk factor to the AKI alarm model can improve the accuracy of early prediction of AKI. This evidence concerns the gene ATF3 and acute kidney injury.